Effects of Standing on Non-Ambulatory Children With Spinal Muscular Atrophy
1 other identifier
interventional
4
1 country
1
Brief Summary
Non-ambulatory children with a neuromuscular disability such as spinal muscular atrophy (SMA) are at significant risk for poor bone health as defined by low bone mineral density (BMD) and increased propensity to fracture. Poor bone health is thought to be related, at least in part, to abnormally low levels of load experienced by the skeleton. A common physical approach for increasing bone density is to stimulate the musculoskeletal system by increasing the amount and duration of weight-bearing in the lower extremities. For non-ambulatory individuals, this takes the form of using an assisted standing device to enable the child to spend time in a standing position with some degree of weight placed on the lower limbs. Some of these physical interventions demonstrate variable improvement in BMD in children with neuromuscular conditions, and some do not. A serious limitation in the previous work in this area is a failure to objectively measure the magnitude and duration of the loading experienced by the lower extremities. Thus, a lack of change in BMD may be due to the extremities experiencing only a fraction of the body weight (due to load-sharing with the assistive device) for an inadequate duration of standing time. In order to investigate the efficacy of standing treatment for increasing BMD, the investigators will develop a simple, portable and inexpensive transducer that will measure the magnitude and time course of the load experienced by the lower extremities of individuals with SMA who use a stationary assisted standing device. The specific goal of this proposed project will be to develop, validate and establish the initial feasibility of such a measurement device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2015
CompletedFirst Posted
Study publicly available on registry
January 19, 2015
CompletedStudy Start
First participant enrolled
September 8, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 25, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 25, 2018
CompletedFebruary 17, 2021
February 1, 2021
1.9 years
January 2, 2015
February 16, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Collection of load magnitude and duration data (Use load-sensing platforms to collect load magnitude and duration during standing treatment program)
Use load-sensing platforms to collect load magnitude and duration during standing treatment program.
12 months
Secondary Outcomes (1)
Bone Mineral Density
12 months
Study Arms (1)
Load-measuring platform
OTHERLoad-sensing platform A load-sensing platform will be placed under each foot of the subject to record the time course of load borne by each of the lower extremities during weight-bearing training in an assisted standing device. Intervention: Assisted Standing Treatment Program. Assisted standing treatment program will gradually increase their duration of standing by up to 75% after the baseline phase.
Interventions
Assisted Standing Treatment Program - Assisted standing treatment program will be gradually increase duration of standing by up to 75% after baseline.
Eligibility Criteria
You may qualify if:
- Age 3-14 years old
- Diagnosed with Spinal Muscular Atrophy (SMA)
- Participating in a standing program using a stationary assisted standing device.
- Gross Motor Function Classification System (GMFCS) Level IV or V
- Parent must be able to provide consent.
You may not qualify if:
- \. Currently on bisphosphonates
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gillette Children's Specialty Healthcarelead
- University of Minnesotacollaborator
Study Sites (1)
Gillette Children's Specialty Healthcare
Saint Paul, Minnesota, 55101, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Walter Truong, MD
Gillette Children's Specialty Healthcare
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2015
First Posted
January 19, 2015
Study Start
September 8, 2016
Primary Completion
July 25, 2018
Study Completion
July 25, 2018
Last Updated
February 17, 2021
Record last verified: 2021-02